Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy

Psoriasis is a genetic chronic disease mediated by the immune system with systemic and cutaneous manifestations that can significantly deteriorate patients’ quality of life. Two–three percent of the population worldwide suffer from psoriasis and it imposes a substantial economic burden on patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Baohua, Jing, Mingyi, Yu, Qianying, Ge, Xiaopei, Yuan, Fan, Shi, Lanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326914/
https://www.ncbi.nlm.nih.gov/pubmed/35950130
http://dx.doi.org/10.5114/ada.2021.108445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326914/
https://www.ncbi.nlm.nih.gov/pubmed/35950130
http://dx.doi.org/10.5114/ada.2021.108445

Ejemplares similares